Molecule ProfilePublished
Olaparib
Olaparib is presented here with its overview, approval history, uses, administration, side effects, precautions, and reference material.
Linked Products
1
FAQs
0
References
0
Products Linked to Olaparib
Explore products in the catalog that are mapped to this molecule.
Oncology
Lynza 150mg Tablet
HETERO HEALTHCARE PVT LTD · 150mg
Lynza 150mg Tablet is available for quote requests and procurement support.
1 Bottle Of 30 TabletsView product
More Molecule Profiles
Browse other published molecule pages in the catalog.
Osimertinib
Osimertinib is an oral third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that irreversibly t…
View molecule pageTucatinib
Tucatinib is an oral small molecule tyrosine kinase inhibitor specifically targeting the HER2 receptor, used primarily in the tre…
View molecule page